ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 1: Certain infectious and parasitic diseasesA30.9

A30.9

Billable

Leprosy, unspecified

Chapter 1:Certain infectious and parasitic diseases

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 A30.9 is a billable code used to indicate a diagnosis of leprosy, unspecified.

Key Diagnostic Point:

Leprosy, also known as Hansen's disease, is a chronic infectious disease caused by the bacterium Mycobacterium leprae. It primarily affects the skin, peripheral nerves, mucosal surfaces, and the eyes. The disease is characterized by the development of skin lesions, which can be hypopigmented or erythematous, and can lead to significant disability if left untreated. Leprosy is transmitted through respiratory droplets, and the incubation period can range from several months to years. The clinical manifestations of leprosy can vary widely, from asymptomatic to severe forms that involve extensive skin and nerve damage. Diagnosis is typically made based on clinical findings and can be confirmed through skin smears or biopsies. Treatment involves multi-drug therapy (MDT) with a combination of rifampicin, dapsone, and clofazimine, which is effective in curing the disease and preventing transmission. However, resistance to these drugs can occur, particularly in areas with high prevalence, making adherence to treatment protocols critical. The unspecified nature of this code indicates that the specific type or severity of leprosy is not documented, which can complicate treatment and management.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variability in clinical presentation and severity of leprosy.
  • Need for accurate documentation of symptoms and treatment response.
  • Potential for misclassification with other mycobacterial infections.
  • Resistance patterns to treatment may complicate coding.

Audit Risk Factors

  • Insufficient documentation of clinical findings.
  • Inconsistent coding of leprosy types.
  • Failure to document treatment adherence and resistance.
  • Lack of follow-up documentation on patient outcomes.

Specialty Focus

Medical Specialties

Infectious Disease

Documentation Requirements

Detailed clinical notes on symptoms, treatment plans, and follow-up care.

Common Clinical Scenarios

Diagnosis and management of leprosy, monitoring treatment response, and addressing complications.

Billing Considerations

Ensure documentation reflects the specific type of leprosy when applicable.

Dermatology

Documentation Requirements

Comprehensive skin examination findings, treatment regimens, and patient education on skin care.

Common Clinical Scenarios

Evaluation of skin lesions, management of skin complications, and patient counseling.

Billing Considerations

Document the extent of skin involvement and any associated nerve damage.

Coding Guidelines

Inclusion Criteria

Use A30.9 When
  • Follow the official ICD
  • CM coding guidelines for infectious diseases, ensuring that the unspecified code is used only when the specific type of leprosy is not documented
  • Include relevant clinical details to support the diagnosis

Exclusion Criteria

Do NOT use A30.9 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

99213CPT Code

Established patient office visit, Level 3

Clinical Scenario

Used for follow-up visits for leprosy management.

Documentation Requirements

Document history, examination findings, and treatment plan.

Specialty Considerations

Infectious disease specialists should ensure comprehensive notes.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of leprosy types, improving data accuracy and treatment tracking. However, the unspecified code may lead to challenges in understanding the patient's condition fully.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of leprosy types, improving data accuracy and treatment tracking. However, the unspecified code may lead to challenges in understanding the patient's condition fully.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of leprosy types, improving data accuracy and treatment tracking. However, the unspecified code may lead to challenges in understanding the patient's condition fully.

Resources

Clinical References

  • •
    World Health Organization - Leprosy

Coding & Billing References

  • •
    World Health Organization - Leprosy

Frequently Asked Questions

What is the significance of using A30.9?

A30.9 is used when the specific type of leprosy is not documented. It is important to ensure that this code is used appropriately to avoid misrepresentation of the patient's condition.